Tuberculous Meningitis in Children:Treatment with Isoniazid and Rifampicin for Twelve Months
J Pediatr 114:875-879, Visudhiphan,P.&Chiemchanya,S., 1989
An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989
Dangers from Methylprednisolone Acetate Therapy by Intraspinal Injection
Arch Neurol 45:804-806, Nelson,D.A., 1988
Aetiological Considerations and Risk Factors for Multi-Infarct Dementia
JNNP 51:1489-1497, Meyer,J.S.,et al, 1988
Nontraumatic Frontal Lobe Hemorrhages:Clinical-computed Tomographic Correlations
Neuroradiology 30:500-505, Weisberg,L.A.&Stazio,A., 1988
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Results of the Seven-Year Prospective Study of Stroke Patients
Stroke 19:942-949, Scmidt,E.V.,et al, 1988
Extracranial Vertebral Artery Dissections:A Review of 13 Cases
Stroke 18:1037-1047, Mas,J.,et al, 1987
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Clinical Assessment of 31 Patients with Wilson's Disease, Correlations with Struct. Changes on MRI
Arch Neurol 44:365-370, Starosta-Rubinstein,S.,et al, 1987
Tuberculous Meningitis:Role of CT in Management and Prognosis
JNNP 50:30-36, Kingsley,D.P.E.,et al, 1987
Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986
Persistent Neurological Deficit Precipitated by Hot Bath Test in Multiple Sclerosis
JAMA 249:1751-1753, Berger,J.R.,et al, 1983
Multiple Sclerosis:A New Perspective on Epidemiologic Patterns
Neurol 32:864-870, Fischman,H.R.,et al, 1982
Prevention of Recurrent Stroke
Jr. , et al, Stroke 12:731-73581., Leonberg,S.C., 1981
Intraspinal Steroid Therapy
Neurol 31:168-171, Bernat,J.L., 1981
Multiple Spontaneous Intracerebral Hematomas:Clinical & Computed Tomographic Correlations
Neurol 31:897-900, Weisberg,L., 1981
Epidemiology of Multiple Sclerosis
Editorial, BMJ 2:l386-l387, 1979, , 1979
Swine Influenza Vaccination in Patients with Multiple Sclerosis
Arch Neurol 35:242, Bamford,C.R.,et al, 1978
Massive Brain Hemorrhage:A Review of 144 Cases & an Examination of Their Causes
Stroke 4:946-954, McCormick,W.F.,et al, 1973
The Geography of Neurology
BMJ 2:506, Spillane,J.D., 1972
Cerebellar Ataxia in Children
Handout & References., Gilbert,J.J., 1850
10 Things You Should Know About Cerebral Amyloid Angiopathy
Stroke 57:e69-e742026, Charidimou,A.,
Clinicopathologic Conference, Lyme Neuroborreliosis and Coinfection with Babesia Microti
NEJM 394:383-391, Case 3-2026, 2026
Stroke Mechanism and Severity after Left Atrial Appendage Occlusion, Insights from the LAAOS III Randomized Clinical Trial
JAMA Neurol 83:76-82, Katsanos,A.H.,et al, 2026
Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026
Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026
Association of Changes in Activity Patterns with Brain Atrophy and Disability Progression in People with Multiple Sclerosis
Neurol 106:e214678, e214742, Fitzgerald,K.C.,et al, 2026
Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome
JAMA Neurol 83:250-258, Lim,T.R.et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Frequency of AQP4 and MOG Antibodies in Patients with Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria
Neurol 106:e214753, Deschamps,R.,et al, 2026
The 2024 McDonld Criteria for Dignosis of Multiple Sclerosis, The Rubber meets the Road
Neurol 106:e214688, Miller, A.E., 2026
A 41-Year-Old Man Presenting with Right Foot Tingling
Neurol 106:214781, Lu,V.,et al, 2026
Diagnostic Value of the Kappa Free light Chain Index to Distinguish MOGAD, NMOSD, and MS
Neurol 106:e214946, Tournier,A.,et al, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Myelitis-Predominant Agressive Phenotype:Unveiling Unique Paterns of Late-Onset Neuromyelitis Optica Spectrum Disorders
Ann Neurol 99:1139-1151, Pu,Y-L.,et al, 2026
Dental Flossing May Lower the Risk for Incident Ischemic Stroke, Cardioembolic Stroke Subtype, and Atrial Fibrillation
Stroke 57:1275-1282, Sen,S.,et al, 2026
A 32-Year-Old Woman with Progressive Vision Loss and Confusion
Neurol 106:e214988, Kumar,A.B.,et al, 2026
A 55-Year-Old Man with Rapidly Progressive Weakness and Numbness
Neurol 106:e218063, Li,X.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Late-Onset Seizures, Etiology and Demographics in US Tertiary Care Epilepsy Centers
Neurol 106:e214948, Blank,L.J.,et al, 2026
Wildfire Smoke Exposure and Incident Dementia
JAMA Neurol 82:40-48, Elser,H.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025